Seed grants favor cancer diagnostics

The latest cancer-research grant postings point to a familiar funding preference: projects that can connect molecular work to a clinical problem, a defined disease setting and a usable diagnostic or treatment pathway. A seed-grant call highlighted this week backs early-stage brain-cancer work on disease understanding, diagnosis and treatment, while the American Cancer Society’s Research Scholar Grants continue to support investigator-initiated cancer research across its priority areas. The two programs differ sharply in size and scope, but they point in the same direction. The smaller grant is built to generate early data in brain cancer. The larger ACS mechanism supports independent researchers over multiple years, including work across the cancer research continuum. ### Which grant notices are driving this conversation? The Uncle Kory Foundation Seed Grant Program, as listed by fundsforNGOs, offers up to $50,000 for one year, with a possible second-year renewal based on progress and available funding. (www2.fundsforngos.org) The listing says the program supports innovative early-stage brain-cancer research projects focused on improving disease understanding, diagnosis and treatment, and names September 1, 2026, as the deadline. The American Cancer Society’s Research Scholar Grants, according to the society’s grant page, support investigator-initiated projects across the cancer research continuum for up to four years at up to $200,000 per year. A separate fundsforNGOs listing described the same mechanism as supporting independent researchers working on innovative cancer projects aligned with ACS priority research areas. (www2.fundsforngos.org) ### Why do these listings point toward diagnostics and translational work? The seed-grant language itself names diagnosis alongside treatment and disease understanding, which puts assay development, biomarker discovery and clinically anchored laboratory research squarely inside the call. Because the grant is aimed at early-stage projects, applicants are likely to be judged in part on whether a proposal can produce preliminary data that supports a larger follow-on study. That is an inference from the program’s structure and award size, not a stated review criterion. (cancer.org) The ACS program is broader, but its official description still favors projects that fit defined priority areas and can be run by independent investigators with institutional support. In practice, that structure tends to reward proposals that can show a clear research question, a feasible workflow and a path to measurable outputs over a multi-year period. The ACS says institutions must provide space and other resources customary for independent investigators. (www2.fundsforngos.org) ### What makes an application more competitive under these signals? ACS said in its summer 2026 grant-cycle changes that current or former Research Scholar Grant awardees generally may not apply for another RSG unless tied to a special funding initiative request for applications. That change raises the stakes for first-time applicants to present a well-defined, durable research program rather than a loosely framed pilot. (cancer.org) Paul Campbell, scientific director of the Cell Biology and Preclinical Cancer Research program at ACS, said in an April ACS research update that Research Scholar Grants “have long been central” to the society’s support for high-quality cancer research. For applicants, that makes project ownership, technical relevance and documented outputs such as posters, abstracts or manuscripts easier to defend than generic lab participation. (cancer.org) ### What does that mean for someone building a proposal now? A proposal built around a named specimen type, a defined biomarker question and a realistic assay workflow is easier to map onto both of these funding signals than a broad “cancer biology” pitch. The same is true for projects that can explain where samples come from, how results would be validated and what clinical decision the work is meant to inform. That framing is an inference from the grant descriptions and from ACS’s emphasis on investigator-initiated projects within priority areas. (cancer.org) The American Cancer Society says grant submissions and post-award administration run through ProposalCentral, where reporting and correspondence are managed. The Uncle Kory Foundation seed-grant listing directs applicants to its posted deadline and program terms, making those pages the next stop for researchers preparing 2026 submissions. (cancer.org) (www2.fundsforngos.org)